Health Plan News

Timely Health Plan News and Commmentary.

Health Plan News
Home Archives for Annalyn Frame

Compare insurances and buy the best one for you

Posted on Written by

In today’s time and age, everything and everyone needs to have indemnity when all sorts of dangers creep around at every corner. It’s no longer a matter of wanting but a matter of needing it. But although you need insurance, you have to be heedful when investing in one because one moment of inattention can cost you a lot of money.

But being busy as you are, can you find the time necessary to find the best offer? Moving from insurance company to insurance company would take up an entire day, if not more. Fortunately the internet comes into play and makes searching for insurance quotes time efficient and easy.

Since all kinds of insurances seem to be almost mandatory, take car insurance for example, many websites surfaced the web to accommodate the demand by offering the possibility to compare insurances over the internet. Although competition between these sites is fierce, all of them were successful enough to get very many visitors each day, which would get their quotes and rates from the sites.

Busy people will find comparing insurances over the internet to be of great value and comfort. These sites do not only show policy prices but also the detailed info for each and every one of the policies.

Getting to do all the insurance comparison from your personal computer without having to actually go to the insurance companies is unquestionably an advantage that only the online insurance comparison sites can offer. The majority of people have found this out so you should take advantage of this as well. However, when searching for insurance quotes, be sure to check out the insurance companies as well. But another great advantage is that you can also check the background of certain insurance companies. Insurance companies are just as important as the insurance that they are marketing. Try to find an insurance company that has aged well in the market and won’t go under in the next few months. Another word of advice goes out for the companies that try to scam people.

Don’t make the misidentify of only visiting the insurance companies’ sites when looking for insurance quotes but search for sites that compare offers head to head. By doing so you ensure that you will get the best insurance that your money can buy.

When searching online for insurance comparisons, keep in mind that you may qualify for cheaper premiums based on the area you live in or on your age. Pay extra attention to the type of insurance company that is offering the quotes.

Private Krankenversicherung Vergleich

Lebensversicherung Vergleich

what is aarp and aarp membership?

Posted on Written by

The AARP applied to be the American Association of Retired Persons.

The AARP is recognized for representing and speaking on behalf of aging populations dependent inside the United States.

It really is included in all kinds of activities for instance:

negotiating reduced rates for prescriptions, housing, tourist attractions, automobile rentalsm motels and hotels.

It truly is at existing included politically with the Medicare Prescription Drug Program.

The AARP was founded in 1958 by Ethel Percy Andrus and hopes to have 70 million members inside the next ten many years because of the increasing age from the US population.

It can be fascinating that the AARP is fighting the proposed alterations to Social Protection.

The AARP has changed its role above the final few decades so as to reflect current living standards as well as the way in which we now method age with dignity and purpose.

On its internet site discounted trips to Hawaii and Alaska are advertised too as news specifically geared to seniors, for example employment news, legal advice, health and fitness info and other fascinating products.

At existing some with the hot button products the AARP is working with are:

Prescription Drug treatments;

Prescription Medicines in excess of the final 5 many years have increased a lot much more rapidly in expenses than the rate of inflation and as this sort of are a heavy burden on Seniors.

The AARP makes offered the final results of studies of modifications in manufacturers’ prescription drug list costs for 200 brand name and 75 generic medicines most widely applied by Americans age 50 and above.

Social Protection;

President Bush appears to believe that there won’t be adequate income within the future to pay for Social Protection advantages for Seniors at today’s level.

His private accounts prepare would permit workers to invest up to a single third of their payroll contributions inside the Stock Current market.

Depending on Stock Marketplace outcomes for your time President Bush has been in office this would have resulted in a loss for that average Senior taking inflation into account.

And also the indexing program that Bush embraced at his April 28 press conference would preserve the existing defined-benefit strategy only for low-wage workers—those currently earning less than about $20,000.

For everybody else, 70 percent of workers, the system would be flipped upside down—so that the a lot more you earn and pay in, the far more your advantages are cut.

Consumer alerts;

Final year Americans spent far more than $20 billion on anti-aging solutions of which a sizeable quantity was for so known as “snake oil” solutions including “human growth hormone ” pills which sold for $80 per bottle per month and promised to cure anything that ails you.

Former Illinois State Senate President Emil Jones Jr. Joins Zimek Technologies Advisory Board

Posted on Written by

SOURCE: Zimek Technologies

TAMPA, FL–(Marketwire – August 6, 2010) – Zimek Technologies (www.zimek.com), the industry leader in infection control and biohazard remediation technology, today announced The Honorable Emil Jones Jr. has joined the company’s prestigious Advisory Board. From 2003-2009, Jones served as President of the Illinois State Senate, a position that culminated more than three decades of service in the Illinois legislature. Jones has been a mentor and friend to many politicians over the years including former Illinois State Senator Barack Obama with whom Jones served. Jones is currently a Senior Counselor at Mercury Public Affairs, leading the firm’s operations based in Chicago, Ill.

“Recognized as one of the most effective political leaders in Illinois state history, Emil Jones left an unparalleled legacy of achievement, making lasting contributions throughout the state, particularly in the areas of education, health care and criminal justice,” stated Kurt Grosman, CEO and President of Zimek Technologies. “We are extremely delighted he is joining our team. His contributions will be vital as we continue to spread the word that Zimek’s sophisticated three-dimensional touch-less decontamination technology can effectively defeat and prevent the spread of deadly viruses and bacteria.”

“Zimek’s automatic rapid decontamination and disinfection technology is a powerful addition to our arsenal of weapons to fight infectious diseases and biohazard attacks,” Senator Jones said. “Zimek’s technology can meaningfully help hospitals throughout our country improve infection control quality standards and ensure they use best practices to comply with new federal provisions issued by CMS (Centers for Medicare & Medicaid Services) which encourage hospitals to disclose and, proactively, reduce their healthcare acquired infections (HAIs). HAIs will now be tied to hospital Medicare reimbursement incentives.”

Jones joins other Zimek Advisory Board members including Dr. Brad Spellberg, scientist, researcher and infectious disease specialist at the David Geffen School of Medicine at UCLA and Harbor-UCLA Medical Center; Dr. Peder Bo Nielsen, consultant in Microbiology with the United Kingdom’s North West London NHS Trust; and Dr. Lindsey Shaw, Assistant Professor of Molecular Microbiology at the University of South Florida. (see http://www.zimek.com/advisoryboard.asp).

Zimek Technologies, based in Tampa, Florida, has been developing and marketing its patented automatic Micro-Mist™ decontamination technologies for more than five years. Zimek’s industry-leading technologies are used by the U.S. Department of Homeland Security, Fire and EMS departments, healthcare facilities, public health agencies, transit systems, correctional facilities and local law enforcement agencies across America.

Contact:
Bob Mazza
310-994-4847
Email Contact

QuickMedical Launches New Video Education Webpage: Qtube

Posted on Written by

SOURCE: QuickMedical

Qtube Is the Latest Customer Education Service Offered by QuickMedical; the Free Video Presentations Provide Health Care Professionals With the Latest in Medical Supply and Equipment Updates, Product Education and Usage Information

ISSAQUAH, WA–(Marketwire – August 6, 2010) –  A new simplified and easily accessible video format where the health care professional can go to obtain the latest in medical equipment and supply information and use has finally arrived: Qtube™.

According to one research study, 50% of online retailers in the US added video in some form last year, and 31% of Fortune 500 companies have public blogs that incorporate video blogging.

“Considering that 177 million Americans watch some sort of video online each month, and they saw 4.3 billion ads in June, it’s not surprising why we would add an educational video site,” said Scott Hanna, CEO at QuickMedical®. “With nearly 150 full feature product videos and educational clinics, QuickMedical® and Qtube™ can offer our customers an easy-to-use educational site where they can learn more about the latest in product development, use and technology.”

The majority of Qtube™ product and clinic video presentations are filmed on site at QuickMedical® in their state of the art display and video production room. A number of videos are also supplied to Qtube™ by the QuickMedical® vendor/manufacturers for review and placement on the Qtube™ site.

“Our video/media team put together a dynamic website that will feature future product promotions and will help the QuickMedical® vendors create and use new video content that will promote their goods and services,” said Tim Lightell, Social Media Coordinator at QuickMedical®. “Over a two day period, this June at our open house, we filmed nearly 150 vendor/product presentations and ten educational clinics, so there is a lot of content on the Qtube™ site.”

About QuickMedical® and Qtube™:

QuickMedical® has the professional medical equipment needed by health care providers. Look for diagnostic equipment, exam tables, weighing and measuring devices, and medical basics such as stethoscopes, thermometers, and sphygmomanometers. Qtube™ Videos are supplied by our manufacturers or produced in house by our Production Team. Most videos are shot in our state of the art showrooms. Current displays include medical, surgical, and a pediatric exam rooms. Look for QuickMedical’s® new television commercial, currently airing in the Seattle market on local ABC affiliate KOMO 4.

Scott Hanna
CEO
QuickMedical
888-345-4858
Email Contact

Click here to see all recent news from this company

Quit your day Job and Save your Life

Posted on Written by

For the past decade we have been living in a fast-paced world out there. With all the current advancements in technology competition has grown substantially higher for every field, organization and job opportunity than before. Today most of us not just compete for a job inside a organization with our co-workers but also against people from other nations who are serious about taking your job for themselves.

Globalization is both a boon and a bane depending on where you stand. If you are an employee whom receives very high pay for a function that can be done by another individual for a fraction of what you’re making, then you may have been recently among the list of victims of outsourcing. On the other hand if you’re coming from a less developed nation and had a hard time finding reasonable work to afford your everyday expenses, you might have been a recipient of a outsourced job which provides double the wage that any other local company can provide.

As a result of this kind of level of competition employees are now obligated to become slaves to their employers for concern over giving up their jobs. Multi-tasking is a must for every single position inside the organizational structure to reduce expenses within the labor force. Division of work is mostly a thing of the past. You have to be available to take on any kind of activity vastly related to ones area. Otherwise, you may quit your job and someone else will be delighted to have your role for you.

Doing work 9 hours is hardly adequate to be able to keep up with all the tasks assigned to you. This will gradually lead to overwork. This is one of the biggest difficulties we are facing nowadays. Employers commonly exploit their power to make you replaceable. Globalization has lead to a bad pattern of a worker choosing between working to death and starving to death.

You Might Lose Weight On A High Carbohydrate Diet

Posted on Written by

A startling fact is that carbohydrates are not responsible for making people fat. Don’t feel too badly though, you are not the only person who was sold on the idea that a high protein, low carb diet was the only way to lose weight.

Here is a simple way to show this fact. Think about the vegetarians you know, are there any overweight problems among them? The high protein diets rely on a lot of animal fats and proteins, but these vegetarians don’t eat them. Startling indeed, isn’t it?

Maybe you don’t know any vegetarians. They certainly are hard to find, especially in the Midwest, where I live.

You may wonder about the science involved here. After all, many of those folks promoting the low carb diets are well educated, aren’t they? Being well educated doesn’t mean that you are infallible. Besides, the same science that supports the low carb diet also supports the high carb diet. They didn’t get it wrong, they just didn’t consider the whole story.

That might sound like a contradiction, but it isn’t. I’m going to explain why in just a moment. First, let me give you the science on this. You most likely are not a biochemist or a physiologist and neither am I. But I have studied the subjects a bit. Don’t focus on the technical language in the next paragraph,just try to grasp the overall point. You don’t need to be a scientist to use common sense and basic reasoning skills. Ready?

Consider this bit of biochemistry. Malonyl -CoA exists in high amounts when there is plenty of metabolic fuel present. Thus, carnitine acyltransferase is inhibited and this in turn prevents acyl-CoA from crossing into the cell’s mitochondria. Another enzyme is inhibited by the presence of NADH and Thiolase is also inhibited by the presence of Acetyl-COA. In short, when a lot of glucose is present, fatty acid metabolism is inhibited.

It is the last sentence that clues us in here. Basically, a cell will not convert fat into energy if there is glucose present. When the cell has carbs and sugar to work on, it will not convert the fat to energy, thus the fat gets stored.

This is why the low carb diets work, with little to zero carbohydrates and subsequently glucose to work on, the fat will be used for energy. This is exactly why the high carb diet works too. When no or little fat is present, it won’t be stored as fat.

In addition to this, it is important to realize that it costs the body quite a bit of energy to take carbs and store them as fat. This alone is actually a positive. There really needs to be some form of fat present to make it easier.

This should help you understand that whatever your diet consists of, if you want to remain or get thin, you need to avoid mixing fats and carbs together. A fat consists of a fatty acid head and a carbohydrate tail. This means when you mix your fats and carbs together you are asking for trouble, assuming you care about weight, that is.

So now it should be clear why so many people in North America have a weight loss problem as the NIH was happy to point out a few weeks ag. Think about the typical American diet. It generally consists of lots of combinations of fat and carbs.

As Dr. Neal Barnard points out in his book, “Foods That Cause You To Lose Weight”, It is fat that makes people fat.

Don’t want to be a vegetarian? I don’t blame you. Really, you don’t have to be one. Just quit mixing your proteins/fats and carbohydrates together.

Don’t overlook the obvious, there is ton of candy and desserts out there that are a mixture of fat and sugar. Meat and potatoes – perhaps this classic is a serious blunder in separating fats and carbs. Armed with this knowledge,you can probably come up with dozens of examples of potentially fattening mixtures of food on your own. Candy can ruin a good smile too!  Consider kardashian teeth whitening, but make sure your teeth are strong first!

This article is for information only. It is not intended to prescribe, treat, advise on or diagnose any health problem, including being overweight. Consult your physician before changing your diet or taking up a new form of exercise.

 

Ridding Yourself Of Gingivitis And Bad Breath …

Posted on Written by

Does this sound or seem familiar to you? My dentist and hygienist mentioned that I had irritated gums as they cleaned my teeth. This is a symptom of gingivitis. Gingivitis can be a stepping stone to major problems in the mouth and gum line. It can lead to periodontal disease, which is a much more serious problem with the potential for actual bone loss.

Halitosis (bad breath) could be related to a gingivitis infection as both are caused by bacteria. Red, swollen and/or bleeding gums characterize gingivitis. These symptoms are most evident upon flossing and sometimes from brushing.

Bacteria cause gingivitis. And bacteria are considered to be responsible for bad breath. After you clear up any existing dental disease, it might be time to use whiter teeth. But, definitely get a clean bill of dental health first, before even considering tooth whitening.

Sometimes, I could even see the bloodstains that the hygienist quietly wiped away with a towel. It was embarrassing enough to know that I wasn’t controlling my gingivitis problem, but to know that she was actually trying not to make a big deal out of it was troubling.

I knew my dentist was concerned because she gave me a bottle of alcohol based mouthwash to try and mentioned that she wanted to see how I looked next time. I don’t like using it; there is a little too much alcohol and the taste is not really very pleasant. Alcohol may also dry the mucous membranes in the mouth. On the other hand, a prescription for chlorhexidine gluconate oral rinse uses may have been a better option. But she did not prescribe it and I didn’t know about it at the time.

The Problem

Bacteria can stick to your teeth and secrete acid onto them contributing to cavity formation. They can also infect the gums, particularly around the gum line, causing gingivitis. This can manifest initially as bleeding and irritated gums.

Having a lot of uncontrolled bacteria multiplying in the mouth may also lead to bad breath, but there is a natural and normal amount of bacteria in the mouth, and you will not be able to completely get rid of them all, nor would you want to.

Theory has it that it is actually the anaerobic bacteria that live in the tongue and throat that produce sulfur that in turn produce hard to get rid of bad breath. These anaerobes create VSCs or volatile sulfur compounds. One type is the familiar rotten egg smell. There are other odors coming from VSCs as well. These sulfur-producing bacteria may feed on certain foods, like coffee, alcohol and meats.

A gingivitis problem can offer a way for bacteria to easily enter your blood stream and that can lead to additional problems. Systemic infections could come from this. Gingivitis can be something that makes your gums bleed easily in a mild case or it can be the root of deep gum recession, leading to bone loss in the worse case scenarios. (Periodontal disease)

Loss of gum line can be discouraging. A friend of mind once described the process as, “getting long in the tooth”. Sometimes, people experience this problem by brushing too hard. TIP: Using a soft bristled toothbrush with the type of motion that your hygienist recommends may help prevent eroded gum lines.

Treatment and Prevention

Had you ever heard of under-the-gum cleanings? This could be part of the protocol your dentist might invoke, should you develop periodontal disease. If you know people that have had an under-the-gum cleaning; they may tell you that it is not very pleasant.

Your dentist can deal with this problem in a variety of ways. However, prevention probably is the best option. Include good flossing and brushing habits – see your dentist for details. And you could add a non-alcohol based mouthwash alternative to your regimen.

I am currently using a special toothbrush that vibrates to clean the teeth. This device does a better job than a regular toothbrush in keeping my teeth clean. It does take a little while to get used to because of the vibration. It makes many, many vibrations per second. This helps to give it such wonderful cleaning abilities.

Do not feel sad if you have excellent oral health habits but you still have halitosis. This is common and many people experience this same situation. Oral health products, such as therabreath coupons, that don’t contain sodium lauryl sulfates or artificial flavors that can still kill the bacteria that cause bad breath without using harsh alcohol or tough chemicals may be helpful.

I am not a dentist. This article is only for information purposes. This article is not meant for diagnosis, treatment or prevention nor is it meant to give advice. If you have or think you have gingivitis, periodontal disease or any other dental problems, visit your dentist for a consultation.

Extendicare REIT Announces 2010 Second Quarter Results

Posted on Written by 

                              EXTENDICARE REIT                              
                      Condensed Consolidated Earnings                       
(thousands of Canadian dollars      Three months ended     Six months ended 
 except per unit amounts)                 June 30               June 30     
----------------------------------------------------------------------------
                                      2010       2009       2010       2009 
----------------------------------------------------------------------------
Revenue                                                                     
Nursing and assisted living centers                                         
  United States                    337,596    371,990    673,719    769,099 
  Canada                           122,959    118,860    241,543    233,244 
Home health - Canada                38,362     38,819     77,891     74,823 
Health technology services                                                
 - United States                     4,139      4,794      8,285     10,245 
Outpatient therapy - United States   3,758      3,505      6,694      7,236 
Other                                7,557      8,631     15,073     17,593 
----------------------------------------------------------------------------
                                   514,371    546,599  1,023,205  1,112,240 
Operating expenses                 424,567    452,589    853,863    931,659 
Administrative costs                17,505     18,917     34,484     38,836 
Lease costs                          2,612      3,097      5,420      6,191 
----------------------------------------------------------------------------
EBITDA (1)                          69,687     71,996    129,438    135,554 
Depreciation and amortization       15,785     16,350     31,479     33,709 
Accretion of asset retirement                                               
 obligations                           393        416        793        853 
Interest expense                    22,800     24,479     45,994     50,316 
Interest income                     (2,074)      (709)    (3,002)    (1,851)
Loss (gain) on derivative financial                                         
 instruments and foreign exchange    4,505    (12,424)     1,285     (7,474)
Loss from asset impairment,                                                 
 disposals and other items           2,580        594      2,580        337 
----------------------------------------------------------------------------
Earnings from continuing                                                    
 operations before income taxes     25,698     43,290     50,309     59,664 
----------------------------------------------------------------------------
Income tax expense (recovery)                                               
Current                             11,244     14,958     22,650     25,911 
Future                                 476     (1,206)    (1,475)       397 
----------------------------------------------------------------------------
                                    11,720     13,752     21,175     26,308 
----------------------------------------------------------------------------
Earnings from continuing                                                    
 operations                         13,978     29,538     29,134     33,356 
Discontinued operations               (974)       706       (564)       545 
----------------------------------------------------------------------------
Net earnings                        13,004     30,244     28,570     33,901 
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Basic and Diluted Earnings per Unit ($)                                     
Earnings from continuing operations   0.17       0.40       0.36       0.45 
Net earnings                          0.16       0.41       0.36       0.46 
----------------------------------------------------------------------------
(1) Refer to discussion of non-GAAP measures.                               
----------------------------------------------------------------------------
Certain 2009 figures have been revised for comparative purposes.            
                                                                            
                              EXTENDICARE REIT                              
                   Condensed Consolidated Balance Sheets                    
(thousands of Canadian dollars, unless             June 30      December 31 
 otherwise noted)                                     2010             2009 
----------------------------------------------------------------------------
Assets                                                                      
Current assets                                                              
  Cash and short-term investments                  252,542          134,012 
  Restricted cash                                   19,322           22,361 
  Accounts receivable, less allowances             211,563          213,477 
  Income taxes recoverable                           8,500           29,314 
  Future income tax assets                          24,338           24,900 
  Other current assets                              25,017           22,187 
----------------------------------------------------------------------------
                                                   541,282          446,251 
Property and equipment, including construction-in                           
 -progress of $50,880 and $41,956, respectively    865,132          863,430 
Goodwill and other intangible assets               194,883          191,514 
Other assets                                       152,536          166,870 
----------------------------------------------------------------------------
                                                 1,753,833        1,668,065 
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Liabilities and Equity                                                      
Current liabilities                                                         
  Accounts payable                                  37,708           38,372 
  Accrued liabilities                              232,674          245,260 
  Accrual for self-insured liabilities              11,505           11,321 
  Current portion of long-term debt                 99,013           28,538 
----------------------------------------------------------------------------
                                                   380,900          323,491 
Accrual for self-insured liabilities                29,126           32,562 
Long-term debt                                   1,157,975        1,205,494 
Other long-term liabilities                         68,173           67,555 
Future income tax liabilities                       75,799           79,866 
----------------------------------------------------------------------------
                                                 1,711,973        1,708,968 
Unitholders' equity (deficiency)                    41,860          (40,903)
----------------------------------------------------------------------------
                                                 1,753,833        1,668,065 
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Closing US/Cdn. dollar exchange rate                1.0646           1.0510 
----------------------------------------------------------------------------
                                                                            
                              EXTENDICARE REIT                              
                     Condensed Consolidated Cash Flows                      
                                  Three months ended      Six months ended 
(thousands of Canadian dollars)         June 30                June 30 
----------------------------------------------------------------------------
                                   2010        2009        2010        2009 
----------------------------------------------------------------------------
Operating Activities                                                        
Net earnings                     13,004      30,244      28,570      33,901 
Adjustments for:                                                            
  Depreciation and amortization  15,785      16,782      31,479      34,665 
  Provision for self-insured                                                
   liabilities                    3,942       4,988       9,433      10,313 
  Payments for self-insured                                                 
   liabilities                   (8,536)     (4,443)    (11,659)     (7,563)
  Future income taxes              (999)     (1,204)     (2,950)        391 
  Loss (gain) on derivative financial instruments                           
   and foreign exchange           4,505     (12,424)      1,285      (7,474)
  Loss from asset impairment,                                               
   disposals and other items      2,580         594       2,580         337 
  Loss (gain) from asset disposals,                                         
   impairment and other items from                                          
   discontinued operations        2,751           -       2,751      (1,426)
  Other                           2,596       2,866       5,229       6,205 
----------------------------------------------------------------------------
                                 35,628      37,403      66,718      69,349 
----------------------------------------------------------------------------
Net change in operating assets and liabilities                              
  Accounts receivable            10,475       9,320       2,148      24,903 
  Other current assets              513         608      (2,650)     (6,002)
  Accounts payable and                                                      
   accrued liabilities          (15,394)     (4,555)    (16,930)    (12,064)
  Income taxes                   11,133      (8,345)     19,633      (4,843)
----------------------------------------------------------------------------
                                  6,727      (2,972)      2,201       1,994 
----------------------------------------------------------------------------
                                 42,355      34,431      68,919      71,343 
----------------------------------------------------------------------------
Investing Activities                                                        
Growth capital expenditures      (6,901)    (12,518)    (18,517)    (25,789)
Maintenance capital expenditures (5,173)     (7,917)     (9,759)    (15,241)
Net proceeds from dispositions    5,482           -       5,482       9,995 
Other assets                       (490)        384      (1,185)     (1,710)
----------------------------------------------------------------------------
                                 (7,082)    (20,051)    (23,979)    (32,745)
----------------------------------------------------------------------------
Financing Activities                                                        
Issue of long-term debt           9,427       6,337      30,138      12,049 
Repayment of long-term debt      (6,957)     (3,895)    (20,365)    (14,135)
Decrease (increase) in                                                      
 restricted cash                  3,039     (29,482)      3,039     (29,482)
Decrease in investments held                                                
 for self-insured liabilities     7,950       6,536       8,278       7,091 
Purchase of securities for                                                  
 cancellation                         -           -           -      (6,189)
Distributions paid              (15,968)    (14,584)    (31,086)    (30,866)
Issue of units                        -           -      82,212           - 
Financing costs                    (476)     (2,795)       (740)     (2,832)
Other                               (95)       (330)        (95)     (1,860)
----------------------------------------------------------------------------
                                 (3,080)    (38,213)     71,381     (66,224)
----------------------------------------------------------------------------
Foreign exchange gain (loss) on cash                                        
 held in foreign currency         4,457      (1,704)      2,209        (851)
----------------------------------------------------------------------------
Increase (decrease) in cash                                                 
 and cash equivalents            36,650     (25,537)    118,530     (28,477)
Cash and cash equivalents at                                                
 beginning of period            215,892     120,144     134,012     123,084 
----------------------------------------------------------------------------
Cash and cash equivalents at                                                
 end of period                  252,542      94,607     252,542      94,607 
----------------------------------------------------------------------------
----------------------------------------------------------------------------
                                                                            
                              EXTENDICARE REIT                              
                     Financial and Operating Statistics                     
                                                                            
                                     Three months ended    Six months ended 
                                                June 30             June 30 
----------------------------------------------------------------------------
(amounts in Canadian dollars, unless                                        
 otherwise noted)                        2010      2009      2010      2009 
----------------------------------------------------------------------------
Earnings from Continuing Operations (millions)                              
United States (US$)                     $11.8     $20.7     $22.9     $25.8 
----------------------------------------------------------------------------
United States                           $12.1     $24.8     $23.6     $31.1 
Canada                                    1.9       4.7       5.5       2.2 
----------------------------------------------------------------------------
                                        $14.0     $29.5     $29.1     $33.3 
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Net Earnings (millions)                                                     
United States (US$)                     $10.8     $21.4     $22.3     $26.3 
----------------------------------------------------------------------------
United States                           $11.2     $25.5     $23.1     $31.7 
Canada                                    1.9       4.7       5.5       2.2 
----------------------------------------------------------------------------
                                        $13.1     $30.2     $28.6     $33.9 
----------------------------------------------------------------------------
----------------------------------------------------------------------------
U.S. Skilled Nursing Center Statistics                                      
 Percent of Revenue by Payor Source (same-facility basis, excluding prior   
  period settlement adjustments)                                            
 Medicare (Parts A and B)                33.3%     34.1%     33.1%     34.4%
 Managed Care                             9.5       9.6       9.5       9.5 
----------------------------------------------------------------------------
 Skilled mix                             42.8      43.7      42.6      43.9 
 Private/other                            9.0       9.4       9.1       9.3 
----------------------------------------------------------------------------
 Quality mix                             51.8      53.1      51.7      53.2 
 Medicaid                                48.2      46.9      48.3      46.8 
----------------------------------------------------------------------------
                                        100.0     100.0     100.0     100.0 
----------------------------------------------------------------------------
----------------------------------------------------------------------------
 Average Daily Census by Payor Source (same-facility basis)                 
 Medicare                               2,342     2,385     2,334     2,441 
 Managed Care                             802       797       808       802 
----------------------------------------------------------------------------
 Skilled mix                            3,144     3,182     3,142     3,243 
 Private/other                          1,425     1,518     1,427     1,516 
----------------------------------------------------------------------------
 Quality mix                            4,569     4,700     4,569     4,759 
 Medicaid                               9,440     9,490     9,498     9,513 
----------------------------------------------------------------------------
                                       14,009    14,190    14,067    14,272 
----------------------------------------------------------------------------
----------------------------------------------------------------------------
 Average Revenue per Resident Day by Payor Source (excluding prior period   
  settlement adjustments) (US$)                                             
 Medicare Part A only                $ 457.74  $ 454.38  $ 457.40  $ 451.03 
 Medicare (Parts A and B)              499.77    497.31    499.87    492.07 
 Managed Care                          415.60    417.72    412.75    415.12 
 Private/other                         223.73    215.17    224.59    213.52 
 Medicaid                              179.79    172.06    179.60    172.10 
 Weighted average                      252.63    245.14    252.02    244.88 
----------------------------------------------------------------------------
Average Occupancy (excluding managed centers) (same-facility basis)         
U.S. skilled nursing centers             86.9%     88.3%     87.2%     88.8%
U.S. assisted living centers             78.3      82.6      78.3      82.6 
Canadian centers                         98.3      97.9      98.1      97.8 
----------------------------------------------------------------------------
Average US/Cdn. dollar exchange rate   1.0277    1.1672    1.0338    1.2062 
----------------------------------------------------------------------------
                                                                            
                              EXTENDICARE REIT                              
                  Supplemental Information - FFO and AFFO                   
The following table provides a reconciliation of EBITDA to Funds from       
Operations (FFO), Distributable Income (DI) and Adjusted Funds from         
Operations (AFFO) for the periods ended June 30, 2010 and 2009.(1)          
                                    Three months ended     Six months ended 
                                          June 30               June 30    
----------------------------------------------------------------------------
(thousands of Canadian dollars                                              
 unless otherwise noted)              2010       2009       2010       2009 
----------------------------------------------------------------------------
EBITDA from continuing                                                      
 operations                         69,687     71,996    129,438    135,554 
Depreciation for furniture, fixtures,                                       
 equipment and computers            (5,580)    (5,983)   (11,033)   (12,049)
Interest expense, net              (20,726)   (23,770)   (42,992)   (48,465)
----------------------------------------------------------------------------
                                    43,381     42,243     75,413     75,040 
Current income tax expense (2)     (11,244)   (15,448)   (22,650)   (26,911)
----------------------------------------------------------------------------
FFO (continuing operations)         32,137     26,795     52,763     48,129 
Amortization of financing costs      2,184      2,841      4,353      5,365 
Principal portion of government                                             
 capital funding payments              615        574      1,226      1,150 
----------------------------------------------------------------------------
DI (continuing operations)          34,936     30,210     58,342     54,644 
Additional maintenance capital                                              
 expenditures (3)                      407     (1,934)     1,274     (3,192)
----------------------------------------------------------------------------
AFFO (continuing operations)        35,343     28,276     59,616     51,452 
AFFO (discontinued operations)(4)      302      1,161        731      2,362 
----------------------------------------------------------------------------
AFFO                                35,645     29,437     60,347     53,814 
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Per Basic Unit ($)                                                          
FFO (continuing operations)          0.393      0.367      0.658      0.660 
AFFO (continuing operations)         0.431      0.388      0.743      0.706 
AFFO                                 0.435      0.404      0.752      0.738 
----------------------------------------------------------------------------
Per Diluted Unit ($)                                                        
FFO (continuing operations)          0.365      0.340      0.620      0.618 
AFFO (continuing operations)         0.390      0.349      0.676      0.639 
AFFO                                 0.393      0.362      0.684      0.666 
----------------------------------------------------------------------------
Distributions declared              17,346     15,317     34,019     30,602 
Distributions declared per unit ($) 0.2100     0.2100     0.4200     0.4200 
----------------------------------------------------------------------------
Basic weighted average number of                                            
 units (thousands)                  82,576     72,914     80,221     72,913 
Diluted weighted average number                                             
 of units (thousands)               96,389     86,727     94,034     86,733 
----------------------------------------------------------------------------
1. "EBITDA", "funds from operations", "distributable income" and "adjusted  
   funds from operations" are not recognized measures under GAAP and do not 
   have a standardized meaning prescribed by GAAP. Refer to the discussion  
   of non-GAAP measures.                                                    
2. Excludes current tax with respect to the loss (gain) from derivative     
   financial instruments, foreign exchange, asset impairment, disposals and 
   other items that are excluded from the computation of AFFO.              
3. Represents total facility maintenance capital expenditures less          
   depreciation for furniture, fixtures, equipment and computers already    
   deducted in determining DI.                                              
4. The impact of discontinued operations reduces FFO, DI and AFFO by the    
   same amount.                                                             
----------------------------------------------------------------------------
                                                                            
Reconciliation of Cash Provided by   Three months ended    Six months ended 
  Operating Activities to DI & AFFO       June 30               June 30 
----------------------------------------------------------------------------
(thousands of Canadian dollars)       2010       2009       2010       2009 
----------------------------------------------------------------------------
Cash provided by operating                                                  
 activities                         42,355     34,431     68,919     71,343 
Add (Deduct):                                                               
Net change in operating assets                                              
 and liabilities                    (6,727)     2,972     (2,201)    (1,994)
Current tax expense on gain or loss                                         
 from derivative financial instruments,                                     
 foreign exchange, asset impairment,                                        
 disposals and other items             (12)      (490)       (12)     1,250 
Net provisions and payments for                                             
 self-insured liabilities            4,594       (545)     2,226     (2,750)
Depreciation for furniture, fixtures,                                       
 equipment and computers            (5,580)    (5,983)   (11,033)   (12,049)
Principal portion of government                                             
 capital funding payments              615        574      1,226      1,150 
Other                                   (7)       412        (52)        56 
----------------------------------------------------------------------------
DI                                  35,238     31,371     59,073     57,006 
Additional maintenance capital                                              
 expenditures                          407     (1,934)     1,274     (3,192)
----------------------------------------------------------------------------
AFFO                                35,645     29,437     60,347     53,814 
----------------------------------------------------------------------------
----------------------------------------------------------------------------

eHealth, Inc. to Present at the Oppenheimer & Co. Inc. Annual Technology, Media & Telecommunications Conference

Posted on Written by

SOURCE: eHealth, Inc.

MOUNTAIN VIEW, CA–(Marketwire – August 5, 2010) –  eHealth, Inc. (NASDAQ: EHTH), the nation’s leading online source of health insurance for individuals, families, seniors and small businesses, today announced that its senior management will present at Oppenheimer & Co. Inc.’s Annual Technology, Media & Telecommunications Conference on Wednesday, August 11 at 8:30 a.m. ET. This event will be held at the Four Seasons Hotel in Boston, MA.

Interested investors can access the live audio webcast of each presentation at www.ehealthinsurance.com under Investor Relations. Please visit the website at least 15 minutes early to register, download, and install any necessary software. A replay of each event will be available on the company’s website shortly after the conclusion of the event and will remain available for 14 days.

About eHealth, Inc.

eHealth, Inc. (NASDAQ: EHTH), the parent company of eHealthInsurance and PlanPrescriber, is the nation’s leading online source of health insurance for individuals, families, seniors and small businesses. Through the company’s websites (http://www.eHealthInsurance.com, http://www.PlanPrescriber.com and http://eHealthMedicare.com), consumers can get quotes from leading health insurance carriers, compare plans side by side, and apply for and purchase individual and family, Medicare, small group, short-term and ancillary health insurance products. eHealthInsurance is authorized by more than 180 of the nation’s leading health insurance companies and offers thousands of health plans. eHealthInsurance is licensed to sell health insurance in all 50 states and the District of Columbia, making it an excellent model of a successful, high-functioning health insurance exchange. Through its eCommerce On-Demand solution (eOD), http://www.ehealth.com/eOD/, eHealth is also a leading provider of on-demand e-commerce software services for health plan providers. eHealthInsurance and eHealth are registered trademarks of eHealthInsurance Services, Inc. PlanPrescriber is a registered trademark of PlanPrescriber, Inc.

For more information, please contact:
Market Street Partners
Phone: (415) 445-3236
Email: [email protected]

Titan Commercial Completes Medical Office Lease

Posted on Written by

SOURCE: Titan Commercial

Health Resource Solutions Relocating to Lombard, Ill.

CHICAGO, IL–(Marketwire – August 5, 2010) –  Titan Commercial today announces the completion of a lease for 9,620 square feet located at 1806 S. Highland Ave. in Lombard, Ill. Ben Rosenfield, principal of Titan Commercial, represented the tenant Health Resource Solutions (HRS) in their relocation and helped facilitate the transaction with landlord StoneCreek Properties, represented by Cawley Chicago Commercial. HRS executed a primary term of 10 years.

“With so much vacant space in the market, we wanted to ensure that we found the best deal, location and landlord to work with. Ben Rosenfield was an excellent resource and negotiated an amazing deal on our behalf that surpassed our expectations,” said Glenn Steigbigel, President of HRS.

Health Resource Solutions is a privately owned hi-tech home health company committed to serving healthcare professionals and patients. Open 365 days a year, HRS provides quality care for patients of all ages including hi-tech geriatric and pediatric nursing, physical therapy, occupational therapy, speech therapy, telemonitoring, and all other necessary coordinated services. They are currently located at 1700 W. Hubbard Street in Chicago. For more information visit the HRS website at www.healthrs.net.

Founded in 2007, Titan Commercial is a commercial real estate brokerage firm whose mission is to improve the lives beyond those involved in the negotiation. While specializing in the acquisition, disposition and leasing of commercial real estate properties, this full service firm has completed over $200 million in transactions and is active in representing landlords, tenants, sellers, purchasers and investors nationwide. Headquartered in Illinois, Titan Commercial also has an office in Arizona. For more information, visit www.titancommercialrealestate.com or call 312.373.7100.

For More Information:
Emily VanderBeek
Marketing Director
312.373.7100

Click here to see all recent news from this company

Number of Homeless Prisoners in Toronto Area Jails Increasing

Posted on Written by

TORONTO, ONTARIO–(Marketwire – Aug. 5, 2010) – The John Howard Society of Toronto will be releasing ‘Homeless and Jailed: Jailed and Homeless;’ a report on the increasing number of homeless individuals in Toronto area jails who are being released to areas that are unable to provide sufficient resources to aid in reintegration and deter recidivism. John Howard researchers undertook 363 interviews with incarcerated individuals in 2009 and 2010. Among this group, 22.9 percent, or roughly one of every five prisoners, was homeless when incarcerated, that is they were staying in a shelter, living on the street (in places considered unfit for human habitation), in a treatment facility, or staying at the home of a friend, paying no rent. Overall, 32.2 percent, or almost one of every three prisoners had plans upon discharge to go to a shelter, live on the street, or couch-surf at the home of a friend. Another 12 percent of these prisoners are at risk of being homeless since they do not know where they will go.

The report will be released as part of Prisoners Justice Day activities at the Holy Trinity Anglican Church (10 Trinity Square – Bay and Queen – Behind the Eaton Centre) at 12:30pm on August 10th. Prisoner’s Justice Day is an annual memorial day, dedicated to all those who have lost their lives while in custody.

Researchers Amber Kellen and Sylvia Novac will be among the presenters.

Metiscan’s Outpatient Diagnostic Imaging Facility Upgrades to Web 2.0 EHR System

Posted on Written by

SOURCE: Metiscan, Inc.

Eliminates License Fee Per-Study

DALLAS, TX–(Marketwire – August 5, 2010) – Metiscan’s (PINKSHEETS: MTIZ) majority owned subsidiary Schuylkill Open MRI, Inc. (Schuylkill), which is an outpatient diagnostic imaging facility located in Pottsville, Pennsylvania providing Magnetic Resonance Imaging (MRI) services, announced today that it has upgraded its legacy electronic healthcare records (EHR) system to a new Web 2.0 based Health Language Seven (HL7) compliant EHR and practice management system.

The new EHR system enhances practice workflow, improving operational efficiencies which management believes will increase cost savings and aid the center’s staff in providing high quality patient care. The EHR system enables Schuylkill to operate as a virtually paper free and filmless practice and includes features such as patient scheduling, practice management and the electronic archiving and distribution of high-quality MRI images and patient reports. Secure access is available to radiologists and referring physicians from any location having a web-browser and a broadband connection.

Schuylkill historically licensed the use of its former EHR system. Since 2003, Schuylkill has paid a licensing fee on a per-study basis. Going forward Schuylkill has determined to purchase its own EHR system and retain FirstView EHR, Inc. (FirstView), which is also a majority owned subsidiary of Metiscan, to host and administer the system. Purchasing the new EHR system provides Schuylkill with a productivity tool that embraces today’s latest secure web technologies and eliminates the need to pay a third party a license fee on a per-study basis.

About Schuylkill Open MRI, Inc.
Schuykill Open MRI, Inc. (Schuylkill) is an outpatient diagnostic facility located in Pottsville, Pennsylvania providing Magnetic Resonance Imaging (MRI) services. Schuylkill began operations in March 2003 and currently performs MRI exams on a Siemens OPEN MRI platform and a Siemens 1.5T high-field MRI platform. Having both platforms provides Schuylkill flexibility in the studies it can conduct. Schuylkill participates in most major insurance plans and accepts Medicare, Medicaid, Worker’s Compensation claims, Personal Injury Protection (PIP) and Letters of Protection (LOPs). Schuylkill is accredited by the American College of Radiology (ACR) and is a majority owned subsidiary of Metiscan, Inc. 

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan’s actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

Investor Relations:
Big Apple Consulting
(407) 389-5900

Click here to see all recent news from this company

UV Flu Technologies Ships Bacteria Killing UV-400 Air Purifying Units to Leading Medical Training Facility

Posted on Written by

SOURCE: UV Flu Technologies, Inc.

CENTERVILLE, MA–(Marketwire – August 5, 2010) – UV Flu Technologies, Inc. (OTCBB: UVFT) (the “Company”) is very pleased to announce that it has received an order from specialized indoor air quality distributor Puravair for a shipment to the prestigious Miami Anatomical Research Center (“M.A.R.C.”) located in Miami, Florida (www.marctraining.com).

M.A.R.C. is one of the finest medical technology training facilities in the country, offering world class surgical training for a variety of specialties. It is one of the few places in the country offering as many as forty, state-of-the art bio skill lab stations in a hospital style setting alongside custom designed conference and lecture facilities delivering full videoconferencing in a dedicated facility. The introduction of new technologies and medical devices requires constantly evolving expertise and the centre offers training to a huge and skilled market of medical specialists encompassing North, Central and South America, as well as the Caribbean. 

“This order is significant when you consider the client’s needs and perspective,” stated Jack Lennon, President of UV Flu Technologies. “They are an internationally-respected medical facility that instructs a diverse client list of doctors, surgeons and other talented practitioners of the medical profession from throughout the western hemisphere.”

“We trust that other teaching facilities, at home and abroad, will take note and quickly identify that our product offers a cost effective and easy to implement method to increase the overall safety level of any facility by immediately lessening the risk of airborne bacteria, and one that also limits the spread of noxious odors and Volatile Organic Compounds (‘VOC’),” said Mr. Lennon, as he further comments, “The ViraTech UV-400 is specifically designed to kill dangerous strains of bacteria which may present themselves from time to time, while also reducing the levels of other contaminants and odors from the air we breathe.”

Mr. Lennon concluded by saying, “Here is a sale which clearly demonstrates product penetration into a massive market encompassing all forms of medical teaching facilities, as well as businesses such as funeral homes and working pathology labs worldwide. The potential list of users in this sector is huge.”

Further details regarding the Company’s business, financial reports and agreements are filed as part of the Company’s continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission’s (“SEC”) EDGAR database.

About UV Flu Technologies, Inc. (OTCBB: UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality (“IAQ”) industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device.

Notice Regarding Forward-Looking Statements
This news release contains “forward-looking statements” as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

ON BEHALF OF THE BOARD

UV Flu Technologies, Inc.
—————————–
John J. Lennon, President & CEO

Investor Information:
Geaux IR Services, Inc.
Toll-Free: 1-888-355-8838
Email Contact

Click here to see all recent news from this company

New Rasmussen Poll Showing 75% of Americans Support the Use of Medical Marijuana by Adults If Prescribed by a Physician Galvanizing Marijuana, Inc….

Posted on Written by

SOURCE: Marijuana, Inc.

MARINA DEL RAY, CA–(Marketwire – August 5, 2010) –  Marijuana Incorporated (PINKSHEETS: PCIO) (http://www.marijuana-incorporated.com) and Medical Marijuana, Inc. (PINKSHEETS: MJNA) has been galvanized by the New Rasmussen Poll showing 75% of Americans support the use of Medical Marijuana by Adults if prescribed by a physician, up from 63% last October. This number clearly shows that a large majority believes in the efficacy of Cannabis, and is an indication that the 14 States and the District of Columbia, recognizing Medical Marijuana were on the right course in fulfilling the will of their citizens.

“We see these numbers as a ‘Tipping Point,'” stated CEO Bruce Perlowin. “More states that are currently in the process of Legalization efforts will certainly come into the fold and it is also interesting to note that the Poll showed that 95% believe that it is likely that Marijuana will be fully legalized in the next 10 years.

Furthermore, Rasmussen shows that the California Bill to Tax and Regulate Cannabis, Prop 19, has 52% approving while opposed by only 36% indicating strongly that recreational Marijuana will be legal in California in November. Additionally, the City of Detroit is also voting this November to legalize recreational Marijuana.

These facts underscore the decision by PCIO to apply for and receive a name change to “Marijuana, Inc.” and jump into this quickly emerging multi-billion dollar industry. With several divisions being created in Marijuana, Inc., from 420 friendly resorts, to licensing the rights of Medical Marijuana, Inc.’s (PINKSHEETS: MJNA) attractive logo for an entire clothing line, Marijuana, Inc. is positioning itself to be a leader and trend setter in the medical marijuana, cannabis, hemp and related peripheral industries.

About Marijuana, Inc.

Marijuana Inc., a Colorado corporation, is one of the first and most prolific distributors in “The Hemp Network.” The Hemp Network is a division of our sister company, MJNA. Marijuana Inc. invites those that would like to capitalize on this fast growth industry to become a part of The Hemp Network by logging onto http://www.thehempnetwork.com using first name “Marijuana” last name “Inc” and phone # 239-738-0434; 239-738-0434. The company is also the first to develop “420” friendly resorts, through the acquisition of a new division. The company continues to market the world’s most expensive coffee, like the one described in the movie with Morgan Freeman, “The Bucket List,” and this civet coffee will be available in the company’s “420” resorts. Marijuana Inc. has also entered into an agreement to acquire certain marketing rights for a clothing line from Medical Marijuana Inc. and if the agreement is consummated, PCIO will issue shares to MJNA and/or its shareholders.

Forward-Looking Statements

This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law.

Seven keys to Living a Simple Life

Posted on Written by

Find a Life Coach

A simple life is more than just living on a tiny budget. You can be a billionaire and yet live simply, free from excessive worries. You can be the president of a major corporation yet live in complete simplicity. You can be a  salesperson targeting high sales quotas and still live simply.

A simple life is abandoning most unneeded vanities. It means you will have to give up some things in life that you really do not need. A favorite smart term in business today is “prioritizing.” Abandoning is more than just prioritizing. Abandoning is like disposing of garbage because you do not need them. You do not include your garbage in your priority list — you throw them away for good.

A simple life is different from a meaningless life. The former implies simplicity, yet has a purpose. You must have a mission or a goal in life to live it to the fullest. The latter implies having no direction at all. Research has shown that many employees who retire, die 1 to 2 years later. Although stress is not in the equation, these employees might have lost something very significant – having a calling or purpose in life.

 

 

A simple life includes the following seven principles:

1. ELIMINATE SELF-IMPORTANCE.

2. ELIMINATE NEGATIVE STRESS.

3. DESIRE LESS.

4. LAUGH MORE OFTEN.

5. DO NOT BE A PERFECTIONIST.

6. LOVE EVERYTHING.

7. STOP, LOOK, AND LISTEN.

 

The 7 points above are just examples of what makes a life simple. The basic principle is that, the more you cut down excess in your lifestyle — tossing out everything that doesn’t help in building up good values and character, and eliminating anything that promotes self-importance — the simpler life becomes. In some extreme cases, people who are very serious about having a simple life actually quit their high paying  jobs or businesses and retire with their loved ones to their chosen paradise. The idea being that a long, healthy, and happy life is the only thing worth living for. It has been shown that rural folks live longer lives mostly because they are free from the pressures of city life. Simple living often means less, if any, pollution – air, noise, and water. It also constitutes lesser things to worry about. Moving to the city from the countryside has been going on en masse, and people find it more difficult to enjoy a peaceful, quiet, and simple life in the crowded cities.

Try taking the coachability assessment to see if coaching is right for you.

Mariano Jauco has empowered business professionals and individuals by sharing his knowledge to produce a positive change in the world. His personal development techniques and coaching methods will allow you to reach your goals and achieve the success and prosperity you deserve. To subscribe to his newsletter go to www .mylife-coach.net

Get Business Health Insurance Quotes Enter Your ZIP Online Right Now

Posted on Written by

We deliver a no cost tool for business health insurance quotes to find quite a few diverse health insurance rates so your company can offer the greatest health insurance to keep the ideal workers and to present a competitive benefits package. Saving cash without cutting corners too much will serve beneficial to both the business and also the employees. Finding less expensive health insurance is usually a win-win situation for everybody.

Companies, big or smaller, have a strict finances to help keep in mind that takes care of the key areas of running a small business. Health insurance is typically the last thing on a small business ownerís head. Why need to companies provide health insurance? It is a big edge when staff look for jobs. Salary and wages are only one part with the total benefits package. Medicine and physicans cost a ton of money out-of-pocket, and unexpected expenses are not one thing to smile about.

Providing health insurance for your workers will cause your company to stand out as a great place to work and you will have happy workers. Happy workers are undeniably additional productive and will remain at the exact same firm for a long time if they have no cause to leave. By not offering good health insurance, you are giving them a motive to leave. Your competitors probably deliver health insurance, so why shouldn’t your business? Get your health insurance quotes small businesses now.

Each and every employee of a organization deserves a excellent healthcare program from their boss that won’t deny them of their wellbeing desires, regardless of whether it really is prescriptions, surgical procedure, or other medical charges.  Organizations front at the least half of this kind of bill, and also the rest is up towards the worker. Health insurance isn’t anything to be ignored. Every person gets sick or desires attention from a doctor at some point in his or her life.

Modest businesses have the edge of a law that permits everyone, regardless of pre-existing conditions, to obtain covered. Employees, take advantage of your businesses health insurance program. No less than half from the expenses are covered by your employer , and there are many plans to choose from the insurance policies corporation your boss has picked .

Finding Affordable Family Health Insurance

Posted on Written by

The economy being what it is today everybody is looking for ways to cut expenses and save themselves some money, receiving affordable Michigan health insurance is a wonderful spot to start attacking your budget.

 

The easiest way we can assist you to trim back your every month payments is by shopping your health insurance coverage needs among many of the top rated health insurance companies in Michigan.

 

Purchasing affordable Michigan health insurance can save the average family literally hundreds of dollars a month in health insurance premiums. That would easily add up to thousands of dollars per year in savings if you do it right.

 

We always recommend that you always use the services of an licensed independent Michigan health insurance agency.

 

There are several good reasons why we recommend using an independent health insurance agency. To begin with they can shop your family’s heath insurance needs with the assorted health insurance companies that are licensed to do business in Michigan.

 

Having the ability to shop around for the most affordable health insurance policy in Michigan is one of the best ways we know of to assist families in their journey to save money on their family health insurance coverage.

 

If you use the services of a captive agent, that’s the term used for a health insurance agency that represents only one health insurance company, they will only offer you with health insurance quotes from the company they are licensed to represent.

 

Sure, he or she should be able to offer you with multiple quotes on your health insurance, but each quote will still only be a variation of that single health insurance company’s plans. That’s a very important fact to keep in mind if your goal is to save money on your families budget.

 

If you never receive other health insurance companies quotes to compare with, how would you discover if you’re getting the best health insurance coverage at the most competitive price?

 

An independent health insurance agency on the other hand will always produce for you a side-by-side comparison of Michigan health insurance plans from many different health insurance companies.

 

Comparing Michigan health insurance plans side-by-side on an apples-to-apples basis making sure to properly compare the deductibles, out-of-pocket expenses, office visits, and prescription drug benefits, among other factors, is the greatest way you can be sure that the health insurance policy you are about to purchase for your family, is truly the best health insurance option for your situation.

 

Let’s face it, nobody is happy paying the increasing expense of a Michigan health insurance policy these days, that’s why it’s best to see to it that your health insurance needs have been properly shopped and you get multiple quotes from several different health insurance companies, not just several different quotes from the same company.

 

There are many different factors that will determine not only the premium expense of your health insurance coverage, but will also determine whether you will even be able to receive health insurance coverage from a health insurance carrier in the first place.

 

Before we even get started, never cancel a current health insurance policy until you have been approved and received a health insurance policy from another health insurance company.

 

This is an highly important factor, especially if you or anyone in your family has any pre-existing medical conditions. In the case of pre-existing conditions, it is not uncommon to find it rather difficult to find another health insurance provider that would be willing to accept you as a new client. This should change in the near future, but for now that is the way it is.

 

A well seasoned health insurance agency would have already discussed your current medical and prescription drug usage, and should be able to recommend which health insurance companies that would be willing to write certain types of pre-existing conditions, and which companies refuse to accept certain types of pre-existing conditions. 

 

Make sure that the health insurance coverage you are about to receive is a true health insurance plan, and not just some discount health plan. There is a tremendous difference in the coverage protection.

 

We understand there might be a situation where a discount health plan might make financial sense, please be aware that there and night and day differences between regular health insurance, and a discount health plan. We don’t recommend discount health plans if at all possible.

 

Never be afraid to ask questions of your health insurance agent, make sure you understand exactly the type of coverage you’re buying, ask if you’re buying a true health insurance plan, or a discount plan.

 

If you don’t understand your policies coverage’s and limitations, or you’re not sure what type of Michigan health insurance coverage you’re buying, you’re using the wrong health insurance agency to begin with.

 

Can You Help Someone with Cardiopulmonary Resuscitation?

Posted on Written by

First Aid CPR AED

First aid is the provision of initial care for an ill or injured person . It is most of the time performed by a non-expert person to a sick or hurt person until definitive medical treatment can handed over by a more educated medically trained professional. Certain self-limiting illnesses or small injuries is not require advance medical care past the first aid intervention. It generally consists of a series of easy and in some cases, very life-saving techniques that an person could be certified to perform with minimum equipment .

First aid can also be performed on animals; the term generally refers to care of human being . First Aid education is designed to help businesses obey regulatory job site requirements; Safety Training Works, Inc. training programs use a video-based, instructor-facilitated, live reenactment skits, systematic approaching that allows for flexibility and customization by or that meets work-site -specific needs. You can also purchase your pre assemblied first aid kits by clicking on: First Aid Kits

Preserving life

In order to stay alive, all humans need to have an open airway – a clear passage where air can go through the mouth or nose through the pharynx and down in to the lungs, without obstruction. Conscious humans will maintain their own airway automatically, but those who are not responsive may be not able to maintain a clear airway, as the part of the brain which automatically controls breathing in normal situations may not be functioning.

If the patient was breathing, a first aider would commonly then place them in the recovery position, with the person leant over on their side, which also has the solution of clearing the tongue from the pharynx. It also avoids a common cause of death in unconscious person , which is choking on regurgitated stomach contents.

The airway can also become blocked through a foreign object becoming lodged in the pharynx or larynx. And cause them to choke. The first aid responder will be schooled to deal with this through a combination of ‘back slaps’ and ‘abdominal thrusts’.

Once the airway has been opened , the first aid responder should assess to see if the patient is breathing. If there is no breath , or the person is not breathing normally , the first aid responder should undergo which is more than likely the most recognized first aid CPR process – Cardiopulmonary resuscitation or CPR, which means breathing for the person , and manually massaging the heart to get the blood flow around the body.

Promoting recovery

The first aid responder is also certified in dealing with minor injuries such as cuts, grazes or broken bone(s) . They might be able to deal with the problem as a whole with such injuries as a small adhesive patch on a paper cut, or may be required to maintain the condition of something like a bone fracture , until the trained and certified medical professional arrives on site .

Medic First Aid has Award-Winning Training Programs and Products

Safety Training Works, Inc. training programs and products increase the learning process through instructional design and format . Products include Medic First Aid award-winning DVD videos featuring naturalistic scenarios videoed in occupational settings and student packages, including Successful Completion Cards and Certificates. Contact Safety Training Works, Inc. at: http://www.OSHA-safety-regulations.com/contact-us/ and schedule your class today or call Office: (503) 356-0403 Ext. 210 (Oregon) or (425) 531-2246 (Washington).

Find the AAAnswers Launches Podcast and Video Series Focused on Abdominal Aortic Aneurysm (AAA)

Posted on Written by

SOURCE: Find the AAAnswers

Series Provides the Facts About AAA From Physicians, Industry Experts, Patients and Caregivers

SAN FRANCISCO, CA–(Marketwire – August 4, 2010) – Find the AAAnswers, a multi-faceted public education campaign designed to raise awareness of abdominal aortic aneurysms (AAA) and drive at-risk individuals to be screened, today announced the launch of a podcast and video series. Find the AAAnswers developed the series as an alternate avenue to educate consumers about AAA risk factors, and encourage at-risk individuals to be screened for the disease.

Podcast segments will cover a range of topics including:

  • AAA survivor stories from patients and family members
  • AAA in the news
  • Tips for prevention and management of the disease

The first podcast in the series is currently available at http://www.slideshare.net/FindtheAAAnswers/podcast-1 and features a discussion with Find the AAAnswers Coalition partners Dr. Thomas Maldonado and Karen Fitzgerald, NP. Dr. Maldonado, a representative of Peripheral Vascular Surgery Society (PVSS), is also Chief of Vascular Surgery at Bellevue Hospital and Associate Professor of Surgery at NYU School of Medicine. He will provide listeners with an overview of AAA, explain who is potentially at-risk for the disease, and why it is known as a silent killer. Fitzgerald, a member of the Society for Vascular Nursing and Director of Nursing for The Vascular Group, PLLC, discusses the process of an AAA screening, how to discuss AAA with a loved one, and where to turn for more resources.

New podcast segments will be added monthly and available for download on www.FindtheAAAnswers.org and additional audio channels including iTunes and Podcast Alley. 

The first Find the AAAnswers webisode launched today and features impromptu, “man-on-the-street” style interviews with passersby in San Francisco to assess their level of awareness of AAA. Upcoming videos in the series will include behind the scenes looks at local AAA screening events and one-on-one chats with Campaign spokesperson and NFL legend, Joe Theismann. New videos will be added to the series monthly, and available for viewing on the Campaign’s YouTube channel.

Both series will also provide consumers with an opportunity to interact with Find the AAAnswers spokespersons, medical experts and AAA survivors by allowing them to submit their own questions to be posed in upcoming episodes.

About the Find the AAAnswers Campaign
Find the AAAnswers is a multi-faceted public education campaign designed to raise awareness of abdominal aortic aneurysms (AAA) and drive at-risk individuals to be screened. The campaign is supported by the Find the AAAnswers Coalition, an alliance of concerned medical societies, including the American College of Preventive Medicine, Peripheral Vascular Surgical Society, Society for Vascular Nursing, Society for Vascular Surgery and Society for Vascular Ultrasound.

Medtronic, Inc. provides sponsorship for the program due to the lack of awareness and accurate information available to the millions of at-risk Americans. Former professional football quarterback and sportscaster, Joe Theismann serves as the campaign’s spokesperson due to his family history of AAA.


id=”nav_links”>

The Benefits of Final Expense Insurance

Posted on Written by

Have you often wanted to understand more concerning the features of purchasing burial insurance, or final expense insurance, but maybe you weren’t very certain where to begin?

First, let me make clear a bit about what precisely this type of insurance plan is for people that may possibly not be all that familiar with it. Final expense insurance is usually a unique kind of insurance plan that one can obtain so that when they pass away someday, their funeral service and burial expenses will all be handled by the insurance company. This insurance policy can also be used to help settle any hospital expenses or additional financial obligations that you may possibly leave behind soon after your passing.

There are a large variety of advantages to getting this form of insurance coverage. To begin with, just consider what peace of mind it would offer both you and your family knowing that your final expenses will all be covered. Not surprisingly ,, I am confident you wouldn’t want your loved ones to experience a great deal of anxiety because of having to struggle to try to scrape a bunch of dollars together for your funeral costs as well as to pay back any debts which you still owe. As it is, your death would undoubtedly already be a really tough time for them since they would of course be grieving over the loss of you. Nonetheless, should you obtain final expense insurance, then at least your loved ones won’t also have to deal with additional financial stress at the time of your death.

Another benefit to signing up for insurance for one’s last expenses is that a percentage may also be applied as a way to give a charitable donation to somebody. Perhaps there is a specific charitable organization that you have always liked. If so, then you can use some of your insurance plan to give this group some funds, and I’m sure they would definitely be appreciative of the generous gesture. Your last expense insurance plan can also be employed as a way to leave cash behind to your grandchildren or other family members. One wonderful use of this type of insurance plan would be to help begin a college fund for the grandchildren, as this would be an exceptional method to ensure that they will have a bright future ahead of them!

Final expense life insurance really can be a beneficial investment. Should you make a decision to go ahead and obtain it, it will almost certainly bring good peace of mind to both you and your loved ones.  

This Week on ORLive: Live Broadcast of a Total Knee Replacement and Prenatal Pediatric Care

Posted on Written by

SOURCE: OR-Live, Inc.

New On-Demand and Live Surgery Video for the Week of August 2, 2010

WEST HARTFORD, CT–(Marketwire – August 4, 2010) –  ORLive, the vision of improving health, presents a live broadcast of one of the newest total knee systems on the market presented by Wright Labs. Also explore the capabilities available at Morgan Stanley Children’s Hospital’s Center for Prenatal Care, as its world renowned staff presents its capabilities. In addition to these videos, ORLive invites you to take part in the latest installment of the Virtual Brain Tumor Board, and go back to school this month as your watch and learn from this month’s featured channel of medical education content.

NEW ON ORLIVE

LIVE SURGERY VIDEO – EVOLUTION™ Medial-Pivot Knee System
Live Monday, August 2, 2010, 6:00 PM EDT

Designed to replicate the function of a normal knee, the EVOLUTION™ Medial-Pivot Knee is one of the newest total knee systems on the market. This surgery is performed by Dr. David DeBoer, and he’ll answer questions during the broadcast. Learn the latest on the knee system that was built utilizing state-of-the-art design and manufacturing technologies… don’t miss “EVOLUTION™ Medial-Pivot Knee System.”

This surgery video is available to members of the ORLive community, and members can interact and ask questions via the ORLive website. Learn more about this broadcast at ORLive.com, and be ready to view this exciting procedure by activating your free membership to ORLive today.

NOW ON-DEMAND – Prenatal Pediatrics
Now Available On-Demand

Managing a high risk pregnancy can be difficult. NewYork-Presbyterian Morgan Stanley Children’s Hospital provides the maternal, fetal and pediatric expertise to care for high-risk pregnancies. NewYork-Presbyterian Morgan Stanley Children’s Hospital was one of only eight hospitals in the country ranked in each medical specialty measured by U.S. News & World Report, with distinct leadership in neonatology and pediatric cardiac surgery.

Join Dr. Mary D’Alton, Chair, Department of OB/GYN, Columbia University College of Physicians and Surgeons, and a team that includes Dr. Richard Polin, Director, Neonatology, as they review the capabilities and treatments available at the Center for Pediatrics. 

Viewers of this video are invited to interact with the team via the ORLive website, and to join the community and receive regular updates from the NewYork-Presbyterian Morgan Stanley Children’s Hospital Center for Neonatal Pediatrics.

ORLIVE REFERRALS – Week of August 2, 2010
Each week ORLive highlights on-demand videos for our membership and visitors. 

Medical Education Referral: Access to Surgical Intervention for Metabolic Syndrome and Other Diseases from Synovis Life Technologies

CME Referral: The New Frontiers in Atrial Fibrillation from CMEducation Resources

Viewer’s Referral: Webinar Series: Leading Causes of Life Among Those Who Care for Others from Methodist University Hospital

HIGHLIGHTS

NOW ON-DEMAND – Total Thoracoscopic Maze
Now Available On-Demand

The total thoracoscopic maze is a surgical procedure intended to permanently cure atrial fibrillation. This minimally invasive, beating heart procedure will be performed by Dr. Mubashir Mumtaz, Chief of Cardiothoracic Surgery at PinnacleHealth. 

Viewers are still invited to interact with the surgical team by submitting questions via the ORLive website. To learn more about this broadcast go to ORLive.com.

PREVIEW – DePuy® Rotating Platform Revision Knee Replacement
Live August 12, 2010, 7:00 PM

Dr. Russ Nevins will perform a revision total knee replacement using the Sigma® TC3 RP and M.B.T. Revision Tray system from DePuy Orthopaedics, Inc. The broadcast will be moderated by Dr. William Barrett (Renton, WA). This broadcast will take place from Spring Valley Hospital Medical Center in Las Vegas, NV. 

At 4PM Pacific (7PM EDT), Dr. Nevins will perform the revision total knee replacement surgery featuring the Sigma TC3 RP, a rotating platform knee implant design. This system helps diffuse loosening forces from the increased mechanical constraint typical in revision implant systems and offers surgeons enhanced fixation options through the use of metaphyseal sleeves on the femoral and tibial side. 

Viewers are invited to interact with the surgical team by submitting questions via the ORLive website. To learn more about this broadcast and to sign up for an e-mail reminder go to ORLive.com.

About ORLive
ORLive is the leading provider of video communication channels to the healthcare community. Working collaboratively with hospitals and device manufacturers, ORLive produces and distributes customized, interactive, video programs that demonstrate the latest advances in medicine, surgical techniques and product innovations. The ORLive broadcasting network provides an intimate look at over 650 live and on-demand surgeries to a global audience, streaming over 50,000 hours of programming each month. The ORLive network can be found on-line at www.ORLive.com.

Contact:
Bonnie Gergely
Communications Manager
(860) 953-2900
Email Contact

id=”nav_links”>

MedLink Announces Acquisition of Health Informatics

Posted on Written by

SOURCE: MedLink International, Inc.

NEW YORK, NY–(Marketwire – August 4, 2010) –  MedLink (OTCBB: MLKNA), a leading provider of Electronic Health Records and practice management solutions, is pleased to announce the acquisition of Health Informatics, Inc. a provider of cutting edge clinical data digitization technology that simplifies and streamlines the adoption of Electronic Health Records. 

The Health Informatics Digital Pen, in conjunction with MD Form Manager, is the flagship offering of the Company. The Digital Pen looks and feels like a normal ball point pen, however, the Digital Pen contains an integrated infrared digital camera, an advanced image microprocessor and a mobile communications device for wireless connection. The camera records the precise location of ink strokes as it moves over a uniquely constructed grid of microscopic dot patterns. These dots provide the pen with exact co-ordinates of its position, which, through MD Form Manager, are designed to interface directly with the MedLink EHR to collect discrete data elements that electronically populate the patient chart. The solution provides doctors and their staff with the traditional documentation approach of pen and paper, but the advanced ability of digitally documenting and capturing the data required to provide ‘meaningful use’ and other quality data reports.

Ray Vuono, President of MedLink, stated, “We partnered with Health Informatics a little over three months ago to offer the Digital Pen and the immediate reception to the technology in the marketplace was overwhelming. Both parties immediately realized the potential and the overall benefits of a combined solution and we’ve worked diligently over the past few months with Health Informatics to move beyond the inherent limitations of a partnership. The MD Form Manager and Digital Pen provides MedLink with a significant competitive advantage and I’m very excited to welcome Mr. Sayed Alam to the MedLink team, who I’m sure will be one of our most valuable assets. Mr. Alam, the President of Health Informatics, in addition to building a technology platform and enterprise offering, provides MedLink with a wealth of Industry knowledge, foresight and business acumen.”

About Health Informatics

Health Informatics provides cutting edge technology for the automated digitization of patient clinical forms. The solution eliminates the need for a separate digitization process and the associated time and expense involved with traditional paper medical records, by seamlessly integrating digital form with Electronic Health Record (EHR) systems. Please visit www.healthinformatics.us.com, to learn more about the technology and offerings.

About MedLink

MedLink is a healthcare IT company that provides the medical community with products and services designed to help create, manage, and share medical information. The company’s flagship product, MedLink TotalOffice EHR 3.1, a CCHIT Certified® 08 Ambulatory EHR, provides physicians with full EHR and practice management functionality. For more information regarding MedLink’s products and services, please visit www.medlinkus.com.

Safe Harbor Statement

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company’s future performance, as well as management’s expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, outlined in our 2009 Annual Report on Form 10-K available through www.sec.gov. The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

Contact:
Jameson Rose
(631) 342-8800
Email Contact

Hansen Medical Reports 2010 Second Quarter Results

Posted on Written by

SOURCE: Hansen Medical

MOUNTAIN VIEW, CA–(Marketwire – August 4, 2010) – Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in flexible medical robotics and the developer of robotic technology for accurate 3D control of catheter movement, today reported its recent business highlights and financial results for the second quarter ended June 30, 2010.

Recent Business Highlights

  • System Sales: The company recognized revenue on seven Sensei® Robotic Catheter Systems and shipped three systems during the second quarter. Second quarter revenue consisted of one system that was shipped in the quarter and six systems from deferred revenue that had been shipped in prior quarters. From commercial launch in 2007 through June 30, 2010, the company has shipped a cumulative total of 91 Sensei systems worldwide and recognized revenue on a total of 77 systems.
  • Catheter Sales: The company recognized revenue on 555 Artisan™ Control Catheters shipped during the second quarter.
  • Procedures: Electrophysiology procedures performed with Hansen Sensei systems increased over 50% in the first half of 2010 as compared to such procedures performed in the first half of 2009.
  • Vascular Platform: The company announced the successful completion of a pre-clinical in-vivo study evaluating its new vascular robot, which demonstrated improvements in catheter navigation, reduction in vessel trauma during catheter manipulation, and improvements in access time for some vessels, as compared to manual catheter manipulation during endovascular procedures. Results also showed that the company’s vascular robot has the potential to standardize catheter navigation, which may lead to more predictable procedures. The early, but encouraging results were presented June 12, 2010 at the Society of Vascular Surgery’s 2010 Vascular Annual Meeting in Boston.
  • Electrophysiology: The company announced a joint development and cooperation agreement with Siemens Healthcare to co-develop integrated products designed to help simplify complex cardiac procedures for the diagnosis and treatment of cardiac arrhythmias, or irregular heartbeats. The agreements will enable the creation of integrated product solutions by combining Siemens’ Artis zee® family of angiography systems and the syngo® DynaCT Cardiac (angiographic computed tomography) with Hansen Medical’s Sensei® X Robotic Catheter System. The integrated products are being designed to enable electrophysiologists to perform complex cardiac procedures with greater confidence and improved efficiency.
  • Clinical Trial Update: During the second quarter, enrollment began in the company’s conditional IDE clinical trial evaluating use of the Sensei® Robotic Catheter System and the Artisan™ Control Catheter in patients with Atrial Fibrillation (AF).
  • On June 9, 2010 veteran medical device industry executive Bruce J Barclay joined the company as president and chief executive officer, and a member of the Board of Directors. In addition, Frederic H. Moll, M.D. became executive chairman of the Board and Russell C. Hirsch, M.D., Ph.D., transitioned from his former role as chairman of the Board to lead outside director.

“The company is making important progress on several fronts that include key initiatives in growing our EP business, developing and commercializing our vascular platform and improving our operating efficiency,” said Bruce Barclay, president and chief executive officer of Hansen Medical. “During the second quarter, we commenced a previously announced conditional IDE clinical trial using our Sensei Robotic Catheter System for the treatment of patients with AF and results from a recently completed pre-clinical in-vivo study evaluating our new vascular robot validate the important progress of our vascular platform in addressing significant new markets for the company. Finally, while the company successfully raised $29.8 million of capital early in the second quarter, we are continuing to take a hard look at operating expenses while maintaining our focus on our strategic key initiatives.”

2010 Second Quarter Financial Results

Total revenue for the three months ended June 30, 2010 was $7.0 million compared to revenue of $2.9 million in the same period in 2009. During the second quarter, the company recognized revenue on seven Sensei Robotic Systems as well as on shipments of 555 Artisan control catheters. During the quarter the company shipped a total of three systems; one of which was recognized as revenue and two of which will be recognized as revenue as they are installed and physicians are trained, which the company expects will occur during 2010. In addition, six systems from deferred revenue that had been shipped in prior quarters were recognized as revenue in the second quarter of 2010. As of June 30, 2010 the company had a total deferred revenue balance of $10.3 million. The company has shipped 14 Sensei systems that have not been recognized as revenue.

Cost of goods sold for the three months ended June 30, 2010 was $4.5 million and included non-cash stock compensation expense of $156,000. As a result, gross profit for the quarter was $2.5 million and gross margin was 35.7%. This compares to gross profit of $0.3 million and gross margin of 9.7% for the same period in 2009, which included non-cash stock compensation expense of $214,000. Looking ahead for the remainder of 2010, the company expects that cost of goods sold, both as a percentage of revenue and on a dollar basis, will continue to vary from quarter to quarter as manufacturing levels fluctuate and as revenues fluctuate due to changes in system and catheter sales volumes, the timing of revenue recognition on shipped systems, product mix and average sales prices per system and per catheter.

Research and development expenses for the three months ended June 30, 2010, including non-cash stock compensation expense of $372,000, were $6.1 million, compared to $5.0 million for the same period in 2009, which included non-cash stock compensation expense of $688,000. The increase in research and development expenses was primarily the result of development of the company’s vascular system platform. During the remainder of 2010, the company expects research and development expenses to increase from 2009 levels principally due to the on-going vascular system platform development, the atrial fibrillation clinical trial sponsored by the company and engineering activities to support the fiber optic shape sensing and localization technology under our Luna Innovations development agreement.

Selling, general and administrative expenses for the three months ended June 30, 2010, including non-cash stock compensation expense of $504,000, were $7.2 million, compared to $9.9 million for the same period in 2009, which included non-cash stock compensation expense of $1.0 million. The decrease in selling, general and administrative expenses was primarily due to decreased employee-related expenses, related primarily to lower average headcount and a decrease in non-cash stock compensation expense. During the remainder of 2010, the company expects selling, general and administrative expenses to decline from 2009 levels primarily as a result of a decrease in legal and restatement-related expenses.

Other expense, net, for the three months ended June 30, 2010 was $131,000, compared to other expense, net, of $115,000 for the same period in 2009.

Net loss for the three months ended June 30, 2010, including total non-cash stock compensation expense of $1.0 million, was $10.9 million, or $(0.22) per basic and diluted share, based on average basic and diluted shares outstanding of 50.1 million shares. Net loss for the second quarter of 2009, including non-cash stock compensation expense of $1.9 million, was $14.7 million, or $(0.42) per basic and diluted share, based on average basic and diluted shares outstanding of 35.2 million shares.

Cash, cash equivalents and short-term investments as of June 30, 2010 were $44.2 million, compared to $28.3 million as of December 31, 2009. The higher cash, cash equivalents and short-term investments balance is primarily due to the successful completion of a secondary public offering of common stock in the second quarter of 2010, which included the sale of approximately 16.1 million shares with net proceeds to the company, after expenses, of approximately $29.8 million.

Hansen Medical Conference Call

Company management will hold a conference call to discuss its 2010 second quarter results today, August 4, 2010, at 2:00 p.m. Pacific (5:00 p.m. Eastern). Investors are invited to listen to the call live via the Internet using the link available within the “Investor Relations” section of Hansen Medical’s website at www.hansenmedical.com. A replay of the webcast will be available approximately one hour after the completion of the live call. Additionally, participants can dial into the live conference call by calling 888-549-7750 or 480-629-9867. An audio replay will be available approximately one hour after the completion of the conference call through August 11, 2010, by calling 800-406-7325 or 303-590-3030, and entering access code 4333050.

About Hansen Medical, Inc.

Hansen Medical, Inc., based in Mountain View, California, develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. The company’s robotic navigation system enables clinicians to place mapping catheters in hard-to-reach anatomical locations within the heart easily, accurately and with stability during complex cardiac arrhythmia procedures. Hansen Medical’s Sensei® system and its Sensei X Robotic Catheter System are compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data. The remote navigation platform was cleared by the U.S. Food and Drug Administration for manipulation and control of certain mapping catheters in Electrophysiology (EP) procedures. The safety and effectiveness of the Sensei and Sensei X systems for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial fibrillation (AF), have not been established. In the European Union, the Sensei and the Sensei X systems are cleared for use during EP procedures, such as guiding catheters in the treatment of AF. Additional information can be found at www.hansenmedical.com.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause Hansen’s results to differ materially from those expressed or implied by such forward-looking statements. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including statements containing the words “plan,” “expects,” “believes,” “goal,” “estimate,” “enable” and similar words. Hansen intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected in such statements due to various factors, including but not limited to: the effect of credit, financial and general economic conditions on capital spending by our potential customers; risks and uncertainties inherent in our business, including potential safety and regulatory issues that could delay, slow or suspend our clinical trial or our sale efforts, uncertain timelines, costs and results of clinical trials and of developing new products, our ability to effectively sell, service and support our products, the rate of adoption of our systems and the rate of use of our catheters at customers that have purchased our systems, our ability to plan and manage cost-reduction or operational efficiency initiatives, the scope and validity of intellectual property rights applicable to our products and competition from other companies; additional costs and resources necessary to address existing shareholder litigation regarding the restatement of our financial statements; potential claims and proceedings relating to our restatement, such as additional shareholder litigation and any action by the SEC, U.S. Attorney’s Office or other governmental agency which could result in civil or criminal sanctions against the company and/or current or former officers, directors or employees; our ability to remediate material weaknesses in internal controls over financial reporting; and other risks more fully described in the “Risk Factors” section contained in Hansen’s periodic SEC filings, including its Quarterly Report on Form 10-Q filed with the SEC on May 10, 2010.

“Sensei,” “Artisan,” and “CoHesion” are trademarks of Hansen Medical, Inc., and “Hansen Medical,” “Hansen Medical and Heart Logo,” and “Hansen Medical Heart Logo” are registered trademarks of Hansen Medical, Inc. in the United States and other countries. Artis zee and syngo are registered trademarks of Siemens AG.

Condensed Consolidated Statements of Operations (unaudited)
(in thousands, except per share data)

    Three months ended June 30,     Six months ended June 30,  
    2010     2009     2010     2009  
Revenues $ 6,950     $ 2,949     $ 9,661     $ 10,404  
Cost of goods sold   4,472       2,664       8,042       8,045  
Gross profit   2,478       285       1,619       2,359  
Operating expenses:                              
  Research and development   6,073       4,951       10,840       10,602  
  Selling, general and administrative   7,189       9,904       14,920       20,015  
  Gain on settlement of litigation   —       —       (10,003 )     —  
Total operating expenses   13,262       14,855       15,757       30,617  
Loss from operations   (10,784 )     (14,570 )     (14,138 )     (28,258 )
Other income, net   (131 )     (115 )     (623 )     (560 )
Net loss $ (10,915 )   $ (14,685 )   $ (14,761 )   $ (28,818 )
Basic and diluted net loss per share $ (0.22 )   $ (0.42 )   $ (0.34 )   $ (0.95 )
Shares used to compute basic and diluted net loss per share   50,136       35,187       43,873       30,293  

Condensed Consolidated Balance Sheets (unaudited)
(in thousands)

  June 30, 2010   December 31, 2009
Assets
  Cash, cash equivalents and short-term investments $ 44,190   $ 28,279
  Accounts receivable   4,438     6,888
  Inventories, net   6,284     7,406
  Deferred cost of goods sold   2,625     2,535
  Prepaids and other current assets   1,945     1,929
  Property and equipment, net   11,787     13,460
  Note receivable   4,556     —
  Other assets   400     244
             
Total assets $ 76,225   $ 60,741
           
Liabilities and Stockholders’ Equity
Liabilities          
  Accounts payable $ 2,251   $ 2,068
  Deferred revenues   10,273     9,463
  Debt   8,021     9,803
  Other liabilities   6,298     5,654
           
Total liabilities   26,843     26,988
           
Stockholders’ equity   49,382     33,753
           
Total Liabilities and Stockholders’ Equity $ 76,225   $ 60,741
           

Wound Care Products That Reduce Hospital Stays Earn Their Keep

Posted on Written by

SOURCE: Kalorama Information

NEW YORK, NY–(Marketwire – August 4, 2010) –  The need to reduce hospital costs is driving sales of new wound care products, even advanced products with a higher price tag, according to healthcare market research publisher Kalorama Information. Innovations such as biotechnology, biomaterials and tissue engineering will continue to boost revenues, according to its recent report “World Wound Care Markets 2010.” Kalorama estimates the worldwide wound care market reached revenues of $14 billion in 2009 and expects annual growth of over 6% for the next few years.

There have been many research developments in the acceleration of wound healing over the last decade. However, recently these advancements are taking place even more frequently and some of the new products now represent the best new change in the past 30 years. New developments are providing the health care arena of today with some truly sophisticated, highly effective wound care treatments that are poised for growth.

“Many of these new products are proven cost-savers,” said Mary Ann Crandall, analyst for Kalorama Information and author of the report. “There’s always a demand to reduce hospital stays and improve patient outcomes, and a product that can save money in the long run can get a favorable result in reimbursement decisions.”

Wound healing is much like solving a puzzle that involves a series of integrated physiological processes. Various steps must be synchronized and organized in order for everything to fall into place. Without the proper signals at the correct time, a wound cannot heal properly. Having the right tools available, such as appropriate cells, proper nutrition and proper support, is essential. The nature of healing is the same for all wounds with variations depending on the location, severity, and extent of injury. More sophisticated products and a better understanding of the healing processes are increasingly helping to better solve this puzzle.

Beyond new products, Kalorama predicts the market will expand into the future due to demographic factors such as an aging population and an increasing number of sicker patients with more complex coexisting illnesses including diabetes, heart failure, obesity, pulmonary and vascular diseases, immobility issues and chronic wounds. Pressures to cut costs and move patients out of hospitals faster are also leading manufacturers to develop more effective wound care products, according to the report.

The top four wound care companies worldwide include Johnson & Johnson, Kinetic Concepts, Hill Rom and Smith & Nephew. These companies are responsible for about 60% of the revenues of the total market.

“World Wound Care Markets 2010” investigates what the wound care market looks like today; how the market has fared during the recent economic downturn; which segments offer the best market opportunity for companies; and many other key issues and trends. For further information visit: http://www.kaloramainformation.com/redirect.asp?progid=79420&productid=2675467.

About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter (http://www.twitter.com/KaloramaInfo) and LinkedIn (http://www.linkedin.com/groups?gid=2177845&trk=hb_side_g).

Interim HealthCare Announces Franchise Expansion Plans in Philadelphia

Posted on Written by

SOURCE: Interim HealthCare

Healthcare Franchise Leader Hosts Business Opportunities Seminar on August 17

SUNRISE, FL–(Marketwire – August 4, 2010) –  Interim HealthCare® Inc., the nation’s first and finest healthcare and in-home senior care franchise company, is offering Philadelphia residents the opportunity to own their own business with an Interim HealthCare franchise. With a network of more than 300 independently owned franchises across the country, Interim is now seeking franchisee candidates in Philadelphia to be part of an aggressive growth campaign designed to increase its U.S. presence over time. 

Interim’s senior care franchises include non-medical and medical personal care, nursing and healthcare staffing services. The system has a 40 year history within the healthcare industry and many of their franchisees have an average tenure of 24 years.

Executives from Interim will be in town to host a franchise opportunities seminar on August 17 at 7:00 p.m. at the Crowne Plaza – Valley Forge located on 260 Mall Boulevard for all interested candidates. To register for the event and learn more, please log onto www.interimfranchising.com or call 866-767-4730.

“Interim HealthCare has been assisting patients and their families since 1966 and we are excited to expand our footprint in Philadelphia,” said Kathleen Gilmartin, CEO of Interim Healthcare. “We’re looking for interested individuals to join our team who have the sensitivity and compassion needed in our business to help our customers when it matters most.”

Currently with more than15 locations in Pennsylvania, Interim is looking to expand its presence throughout the state by indentifying eight new openings in Philadelphia over four years. Qualified candidates should possess a minimum net worth of $400,000, and a minimum liquidity of $50,000. Franchisees can expect their initial investment to range from approximately $115,500 to $188,500 including the franchise fee.

“Today there are 1 in 8 people 65 or older and by 2030 there will be more than twice that number,” said Gilmartin. “Therefore the growing senior population and home care growth market is a great niche for franchising and with additional Interim HealthCare franchises in the Philadelphia area, we will help the increasing need,” said Gilmartin.

Franchisees utilize comprehensive operations, financial, training, and sales systems to assist in operating their business at maximum efficiency and effectiveness. Additionally, they receive extensive local and national marketing support throughout the year. Interim HealthCare franchise owners share a commitment to improving the lives of their patients and communities, and they continue to realize opportunities for growth in the growing baby boomer segment and home care industry.

About Interim HealthCare:
Founded in 1966, Interim HealthCare® is the nation’s oldest proprietary national health care franchise organization providing health care personnel at all skill levels in all settings. Through a comprehensive network of more than 300 independently owned franchise offices, Interim HealthCare® franchisees are the largest combined provider of community-based home care (skilled and non-medical) and health care staffing. Interim HealthCare is unique in combining the commitment of local ownership with the support of a national organization that develops innovative programs and quality standards that improve the delivery of service through franchisees who employ more than 75,000 health care workers who serve 50,000 people each day. For more information or to locate an Interim HealthCare office, visit www.interimhealthcare.com.

Contact:
Stephanie Goldman
Fish Consulting
954.893.9150
[email protected]

Click here to see all recent news from this company

Bivar Launches ORCAdapt(TM)

Posted on Written by

SOURCE: Bivar

Complete Light Pipe System Couples Superior Brightness With Design Flexibility

IRVINE, CA–(Marketwire – August 4, 2010) –  Bivar, a leading specialty provider of LED indication products and solutions, today announced ORCAdapt™ a complete light pipe system. The new system arms design engineers with a host of options that make moving LED light in existing and emerging applications much easier. The new ORCAdapt solution consists of an ORCA adaptor with a built-in ORCA Super Flux LED and a flexible light pipe system available in 1mm or 2mm size options.

The ORCAdapt unites the well-known brightness and durability of the ORCA Super Flux LED with the optimized light transmission and customized routing of Bivar’s flexible light pipe systems. Bivar’s ORCAdapt is ideally suited for a wide variety of applications such as field instrumentation, heavy equipment, medical devices and transportation.

“The new ORCAdapt brings together a solution that features our ORCA Super Flux LEDs and our 1mm and new 2mm flexible light pipe system,” said Michael Finn, Bivar vice president of sales and marketing. “The ORCAdapt is our answer to customer demand for a complete, cost-effective light pipe system that offers a greater level of design freedom with brilliant light output and high performance.”

The new ORCAdapt light pipe system features Bivar’s ORCA series of Super Flux LEDs, which are an expansion of the company’s high power LEDs designed for use on standard printed circuit boards. ORCA Super Flux LEDs offer greater luminous intensity, higher power efficiency and additional lens configurations while maintaining an industry standard 7.6mm square package form factor. In addition, ORCAdapt supports Bivar’s 1mm and 2mm flexible light pipe systems. The 2mm plastic optical fiber light pipe system is Bivar’s newest addition to the light pipe family and is an ideal LED indication alternative to custom rigid light pipes. The optical fiber maximizes light transmission up to 98 percent, has no light leakage, and is covered with a tough, flexible RoHS compliant PVC alloy outer jacket that maximizes light transmission.

Additional features of the ORCAdapt Complete Light Pipe System:

  • Available in lengths from 2.5″ to 238′;

  • Works with single, bi-color and tri-color ORCA LEDs;

  • Input driven color adjustment capabilities;

  • Simple press fit lens mounting provides rapid installation while retention is vibration and shock resistant.

The new ORCAdapt is immediately available. For more information please visit www.bivar.com. For application assistance and samples, please contact Bivar Sales at [email protected].

About Bivar
Bivar is a leading specialty provider of LED indication products and solutions with a long-standing history of more than 40 years of innovation in the optoelectronics industry. With a global base of customers in 35 countries, Bivar’s products are designed to meet the increased demand for point-to-point indication and address a growing range of industrial markets and applications. Bivar’s focus is on moving and positioning light. An employee-owned company, Bivar’s corporate headquarters are located in Southern California, with manufacturing in California, China and Taiwan. 

Bivar’s Asia Pacific production and logistics centers offer scalable capacity, execution, control and movement of product around the world. Bivar is widely supported by a highly qualified network of authorized representatives and distributors. For more information, please visit www.bivar.com.

Contact:
Stephanie Olsen
Lages & Associates Inc.
949/453-8080
Email Contact

Click here to see all recent news from this company

Renato Corporation Merges With a Major Medical Group, Announces New Board of Directors and Company Business Plan

Posted on Written by

SOURCE: Renato Corporation

MIAMI, FL–(Marketwire – August 4, 2010) –  Renato Corporation (FRANKFURT: 4OZ) is pleased to announce the merger with a major pharmaceutical group in California and Texas as well as 8 medical clinics in California and Arizona. Due diligence has just completed and we look forward to the closing of the merger within the next 14 days.

Healthcare in the United States is undergoing a profound change, driven by both legislation and cost. The new healthcare legislation, the excessive cost of American Health Care, and an estimated 35 million more people under the healthcare will drive the growth of medical clinic groups.

The 8 medical clinics have a combined revenue of $10.5 million dollars.

This group operates 20 natural pharmacies in southern California and Texas and has annual revenues in excess of $8 million, targeted primarily at the Hispanic market, the fastest growing segment of the US population, with vitamins, nutraceuticals and wellness products, the fast growing category of consumer consumption.

The merger of the health clinics with the natural pharmacies is an ideal mix that is designed to enhance the bottom line of both operations with a blend of Hispanic and Non Hispanic clientele.

The established revenues of the properties plus the expected growth of the merged entity will ensure the success of Renato Corporation. The company is in serious discussion with a further 8 groups comprising 27 clinics with revenue in 2010 of approximately $65 million and EBITDA of $14.5 million.

The incoming board comprises Bob Pritchard as Chairman as well as Marketing Director with Dwight Staffelback, BA, MS Public Administration, who will take on the position as CEO, and John Falting is taking up position as Company Secretary for the group.

As of August 2, 2010, the new Board of Directors of Renato Corporation is re-structuring the company’s corporate business plan and is evaluating all existing negotiations and agreements.

www.renatocorp.com, www.renatocorp.de

About Renato Corporation

At Renato Corporation it is the company’s objective to provide diverse early detection diagnostic technologies utilizing its current experience, reputation and expertise within the international health care industry. Introducing and making available these non-invasive technologies through private health care firms and health and wellness centres in an affordable manner is our immediate focus.

The company’s mission is to carefully select where these advanced diagnostic technologies will be placed to ensure unparalleled delivery of customer service and satisfaction in the field of non-invasive early detection disease diagnosis and management.

Innovative information technology platforms are enabling new models for more efficient, effective and safer healthcare delivery. It is inevitable that the economic strain on today’s health care systems worldwide will realize the ever increasing need for early detection diagnostic devices and services.

Disclaimer & Safe Harbor Statement:
This release includes forward looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward looking statements, whether as a result of new information, future events or otherwise. “Safe Harbor” Statement under the U.S. Private Securities Litigation Reform Act of 1995: This release contains certain “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Contact:
Dave Reynolds
Investor Relations
Renato Corporation
305-438-6927
Email: [email protected]

AdCare Closes Exercise of Over-Allotment Option

Posted on Written by

SOURCE: AdCare

SPRINGFIELD, OH–(Marketwire – August 4, 2010) –  AdCare Health Systems, Inc. (NYSE Amex: ADK), an Ohio-based long-term care, home care and management company, has closed the sale of an additional 225,400 shares of common stock at the offering price of $3.50 per share for gross proceeds of $788,900, pursuant to the over-allotment option exercised by the underwriter in connection with AdCare’s offering that closed on June 30, 2010.

The full exercise of the over-allotment option brings the total number of common shares sold by AdCare in the offering to 1,939,686 and gross proceeds to approximately $6.8 million. The aggregate net proceeds to the company from the offering totaled approximately $6.1 million, after deducting underwriting discounts, commissions, legal fees and other offering-related expenses payable by the Company. AdCare plans to use the net proceeds of the offering for acquisition purposes, working capital and general corporate purposes. As of the close of the exercise of the over-allotment, the Company has approximately 7.5 million common shares outstanding.

C. K. Cooper & Company was the sole manager for the public offering.

This press release does not constitute an offer to sell or solicitation of an offer to buy any securities. Any such offer may be made only pursuant to the company’s prospectus supplement and accompanying base prospectus for the offering and only in states in which the offering is registered or exempt from registration and by broker-dealers authorized to do so. The securities offered by the prospectus involve a high degree of risk. Copies of the prospectus supplement and accompanying base prospectus may be obtained from the SEC’s website at www.sec.gov or from C. K. Cooper & Company, 18300 Von Karman Avenue, Suite 700, Irvine, California 92612, Attention: Hue Lapham/Syndicate Department, or [email protected], or via fax +1-949-477-9211.

About AdCare Health Systems
AdCare Health Systems, Inc. (NYSE Amex: ADK) develops, owns and manages assisted living facilities, nursing homes and retirement communities and provides home healthcare services. Prior to becoming a publicly traded company in November of 2006, AdCare operated as a private company for 18 years. AdCare’s 900 employees provide high-quality care, management services and other services for patients and residents residing in 19 facilities, seven of which are assisted living facilities, 11 skilled nursing centers and one independent senior living community. The company owns eight of those facilities. In the ever-expanding marketplace of long-term care, AdCare’s mission is to provide quality healthcare services to the elderly. For more information about AdCare, visit www.adcarehealth.com.

Click here to see all recent news from this company

NicOx to close US headquarters

Posted on Written by

SOURCE: NICOX

SOPHIA ANTIPOLIS, FRANCE–(Marketwire – August 4, 2010) – www.nicox.com

NicOx S.A. (NYSE Euronext Paris: COX) today announced the decision to close
the US headquarters of NicOx Inc. with effect from August 31, 2010. The
decision follows a review of the Group’s structure and requirements after
the US Food and Drug Administration (FDA) said it could not approve its
lead drug candidate naproxcinod, which is expected to at least
significantly delay any potential US launch.

NicOx plans to discuss possible next steps as early as possible with the
FDA and to continue to pursue the European regulatory process for
naproxcinod. NicOx will also actively seek to enter into partnerships for
naproxcinod in Europe and the rest of the world as well as for other
products in its pipeline whilst also pursuing appropriate in-licensing and
M&A opportunities.

The Company had cash and cash equivalents of ?128.4 million at June
30, 2010, and no long-term debt. It also has development partnerships on
its pipeline with Bausch + Lomb, Merck & Co. Inc and Ferrer Grupo.

Michele Garufi, Chief Executive Officer of NicOx, commented: “We very much
regret having to close our operations in the US and we are grateful for the
hard work and dedication of all our employees over the past few years. They
have played a major role in raising awareness among scientists and
clinicians of naproxcinod’s potential medical and clinical value. As we
seek to work out possible next steps for naproxcinod in the US and to
pursue the approval process in Europe, it is essential that we manage our
resources in the most effective manner.”

Risks factors which are likely to have a material effect on NicOx’s
business are presented in the 4th chapter of the ” Document de
référence, rapport financier annuel et rapport de gestion 2009 ”
filed with the French Autorité des Marchés Financiers (AMF) on
March 5, 2010 and available on NicOx’s website (www.nicox.com) and on the
AMF’s website (www.amf-france.org).

The Company notably draws the investors’ attention to the following risk
factors:

– Risques liés à la dépendance de la Société
à l’égard du naproxcinod (Risks related to the Company’s
dependence on the success of its lead product naproxcinod)

– Risques commerciaux et développements cliniques (Clinical
developments and commercial risk)

– Risques liés aux contraintes réglementaires et à la
lenteur des procédures d’approbation (Risks linked to regulatory
constraints and slow approval procedures)

– Manque de capacités dans les domaines de la vente et du marketing
(Lack of sales and marketing capabilities)

– Incertitude relative aux prix des médicaments et aux régimes de
remboursement, ainsi qu’en matière de réforme des régimes
d’assurance maladie (Uncertainty on drug pricing and reimbursement policies
and on the reforms of the health insurance systems)

NicOx (Bloomberg: COX:FP, Reuters: NCOX.PA) is a pharmaceutical company
focused on the research, development and future commercialization of drug
candidates. NicOx is applying its proprietary nitric oxide-donating R&D
platform to develop an internal portfolio of New Molecular Entities (NME)
for the potential treatment of inflammatory, cardio-metabolic and
ophthalmological diseases.

NicOx’s lead investigational compound is naproxcinod, an NME and a first-
in-class CINOD (Cyclooxygenase-Inhibiting Nitric Oxide-Donating) anti-
inflammatory drug candidate developed for the relief of the signs and
symptoms of osteoarthritis (OA). In July 2010, the U.S. Food and Drug
Administration (FDA) provided a Complete Response Letter to the New Drug
Application (NDA) for naproxcinod stating that it does not approve the
naproxcinod application. The naproxcinod Marketing Authorization
Application (MAA) submitted by NicOx in December 2009 is currently under
review by the European Medicines Agency (EMA).

In addition to naproxcinod, NicOx’s pipeline includes several nitric oxide-
donating NMEs, which are in development internally and with partners,
including Merck & Co., Inc. and Bausch + Lomb, for the treatment of
hypertension, cardiometabolic diseases, eye diseases and dermatological
diseases.

NicOx S.A. is headquartered in France and is listed on Euronext Paris
(Compartment B: Mid Caps).

This press release contains certain forward-looking statements. Although
the Company believes its expectations are based on reasonable assumptions,
these forward-looking statements are subject to numerous risks and
uncertainties, which could cause actual results to differ materially from
those anticipated in the forward-looking statements.

For a discussion of risks and uncertainties which could cause actual
results, financial condition, performance or achievements of NicOx S.A. to
differ from those contained in the forward-looking statements, please refer
to the Risk Factors (“Facteurs de Risque”) section of the Document de
Reference filed with the AMF, which is available on the AMF website
(http://www.amf-france.org) or on NicOx S.A.’s website
(http://www.nicox.com).

This information is provided by HUGIN

CONTACTS
www.nicox.com

NicOx Gavin Spencer
Vice President Business Development
Tel +33 (0)4 97 24 53 00
Email Contact

Media Relations Financial Dynamics

Europe
Guillaume Granier (France)
Tel: +33 (0)1 47 03 68 10
Email Contact

Stéphanie Bia (France)
Tel: +33 (0)1 47 03 68 10
Email Contact

Jonathan Birt (UK)
Tel +44 (0)20 7269 7205
Email Contact

United States
Robert Stanislaro
Tel +1 212 850 5657
Email Contact

Irma Gomez-Dib
Tel +1 212 850 5761
Email Contact

NicOx S.A.,
Les Taissounières
Bât HB4 – 1681 route des Dolines
BP313, 06906 Sophia Antipolis cedex, France.
Tel. +33 (0)4 97 24 53 00
Fax +33 (0)4 97 24 53 99

Entity Map

Disclaimer

All content on Health Plan News and information provided on this website is for informational purposes only and is not intended as a substitute for advice from your physician or other healthcare professional. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. Always consult with a healthcare professional before starting any diet, exercise, or supplementation program, before taking any medication, or if you have or suspect you might have a health problem.